Published FDA classification · 5 November 2026
FDA classifies an AI-assisted cytology imaging system
FDA classified a digital cervical cytology slide imaging system with an artificial intelligence algorithm into class II with special controls. The rule identifies the device type and controls for that classification.
What to check Use a classification decision to compare intended use, technology and special controls. Record differences so the regulatory team can assess what evidence they change.
FDA classification rule 2026-22593 (opens in a new tab)